Robert Behl is a serial entrepreneur. After management positions in R&D, marketing, and business development with three major medical device companies, Behl founded and served as GM of Clinical Technology, a unit of tech conglomerate Sybron Corp. He served as CEO and concluded a turn-around of Menlo Care, a venture-funded Raychem Corp spinout. Behl founded InnerDyne and RadioTherapeutics (later sold to Boston Scientific), and Percutaneous Systems. He raised $80MM in venture capital. Behl has engaged in research activities of the Leukemia & Lymphoma Society and the Monterey Bay Aquarium. He chaired the CSUMB College of Science Dean’s Leadership Council and serves as Special Advisor to the Monterey Bay National Marine Sanctuary. Behl holds an MS in Biomedical Engineering from USC.